Results 61 to 70 of about 1,217,759 (290)

Comparative Drug Response Profiling in Neuroblastoma Cell Lines and Patient‐Derived Tumor Organoids

Pediatric Blood &Cancer, EarlyView.
ABSTRACT High‐risk neuroblastoma remains a leading cause of pediatric cancer mortality, and improved preclinical models are needed to guide therapeutic developments. We screened seven high‐risk neuroblastoma cell lines and three patient‐derived tumor organoids with 528 compounds alongside bone marrow controls, and compared them with external datasets ...
Krzysztof Wierbiłowicz, Se Whee Sammy Park, Aironas Los, Ernest Liu, Nona Struyf, Tom Erkers, Sören Lehmann, Jan J. Molenaar, Jakob Stenman, Olli Kallioniemi, Päivi Östling, Brinton Seashore‐Ludlow, Kasper Karlsson   +12 more
wiley   +1 more source

Vaccine effectiveness of the second and third COVID-19 boosters in Belgium (administered during 2022 autumn campaign)

, 2023
In early 2021, the primary vaccination campaign against COVID-19 was rolled out to the adult population in Belgium, followed by the first booster campaign towards the end of the year.
T. Braeye, J. Van Loenhout, E. Vermeiren, V. Stouten, I. Van Evercooren, P. Hubin, M. Billuart, L. Nasiadka   +7 more
core  

Impact of Radiation Therapy on Physical and Psychosocial Health of Adolescents and Young Adults: A Joint Report From the Children's Oncology Group AYA and Radiation Oncology Committees

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Rates of cancer among adolescents and young adults (AYA), age 15–39 years, are increasing. Consequently, radiation oncologists are treating more AYAs who have diagnoses spanning both pediatric and adult practices. Compared to pediatric and older adult patients, AYAs face a unique set of challenges.
Hesham Elhalawani, Rachel K. Peterson, Avani D. Rao, Laurie J. McKenzie, Ahmed Magdy Elmotayam, Leslie Chang, Michael Roth, Susan L. McGovern   +7 more
wiley   +1 more source

Dose calculations for [¹³¹I] meta-iodobenzylguanidine-induced bystander effects

, 2014
Targeted radiotherapy is a potentially useful treatment for some cancers and may be potentiated by bystander effects. However, without estimation of absorbed dose, it is difficult to compare the effects with conventional external radiation treatment ...
R. J. Mairs, Seymour, C B, M. D. Gow, Mairs, R J, C. B. Seymour, Gow, M.D., Mothersill, C.E., Seymour, C.B., C. E. Mothersill, Mairs, R.J., M. Boyd, W. V. Prestiwch, Mothersill, C E, Prestiwch, W V, Prestiwch, W.V., Boyd, Marie, Boyd, M., Gow, M D   +17 more
core   +1 more source

Correlates of protection for booster doses of the BNT162b2 vaccine

, 2022
Abstract Variants of concern (VOC) of SARS-CoV2 and waning immunity pose a serious global problem. Overall, vaccination and prior infection appear to provide significant protection to the majority of individuals, but some remain susceptible to infection and severe disease.
Tomer Hertz, Shlomia Levy, Daniel Ostrovsky, Hannah Oppenheimer, Shosh Zismanov, Alona Kuzmina, Lilach M Friedman, Sanja Trifkovic, David Brice, Lin Chun-Yang, Yonat Shemer-Avni, Merav Cohen-Lahav, Doron Amichay, Ayelet Keren-Naus, Olga Voloshin, Gabriel Weber, Ronza Najjar-Debbiny, Bibiana Chazan, Maureen A. McGargill, Richard Webby, Michal Chowers, Lena Novack, Victor Novack, Ran Taube, Lior Nesher, Orly Weinstein   +25 more
openaire   +2 more sources

Social Functioning Within the First Years After Pediatric Brain Tumor Diagnosis and the Relationship With Family Psychosocial Risk

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Survivors of pediatric brain tumors (PBTs) can experience long‐term social difficulties, impacting quality of life. Beyond medical and environmental factors, family psychosocial risk may play a role in social outcomes by shaping the caregiving environment and may provide intervention options.
Renske H. Houben, Marisa H. Huisman, Martha A. Grootenhuis, Femke K. Aarsen, Marita Partanen   +4 more
wiley   +1 more source

IJCM_294A: COVID-19 vaccination status and willingness for booster dose among staff and students of tertiary care institute

Indian Journal of Community Medicine
Background: Exposure to new COVID-19 variants and decline in herd immunity may result in new or repeat infection. The booster dose may face certain challenges that result in low uptake.
Nikita Sharma, Meenal Madhukar Thakare
doaj   +1 more source

Sports medicine Booster doses are not needed [PDF]

BMJ, 1994
EDITOR, - J C M Sharp's advice on tetanus immunisation1 is contrary to that specified in the current edition of the “green book.” For immunised adults who have received five doses of tetanus vaccine, either as children or according to the recommended schedule of immunisation for those aged 10 years and over, booster doses are not recommended, other ...
openaire   +1 more source

Retrospective Analysis of Donor Lymphocyte Infusions in Pediatric Patients With Mixed Chimerism After Hematopoietic Stem Cell Transplantation

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Allogeneic hematopoietic stem cell transplantation (alloHSCT) is an essential therapy for several malignant and nonmalignant diseases, but relapse and graft loss remain the principal threats to its success. Routine monitoring of chimerism and minimal residual disease (MRD) enables early detection of imminent recurrence and guides ...
Carmen Junk, Sebastian Michaelis, Michaela Döring, Thomas Eichholz, Ursula Holzer, Martin Ebinger, Tim Flaadt, Rupert Handgretinger, Peter Lang, Jan Frederic Weller, Markus Mezger   +10 more
wiley   +1 more source

Increased neonatal vaccine dose or booster immunization prevents hepatitis B vaccine breakthrough infection in children from HBsAg and HBeAg positive mothers

npj Vaccines
Infants born to HBsAg/HBeAg-positive mothers remain risk for hepatitis B virus vaccine breakthrough infection (VBI). In this multicenter prospective cohort study, we assessed whether increased neonatal vaccine dose (20 μg vs.
Yuchen Pan, Yanhua Wu, Jie Wang, Zhifang Jia, Yarong Song, Yi Li, Chong Wang, Jie Li, Jing Jiang   +8 more
doaj   +1 more source